Holding IP Onshore vs Offshore in a Red Chip Structure: What's the Best Approach?

The 2025 revision to the Hong Kong Stock Exchange (HKEX) Listing Decision HKEX-LD150-2025, published in March, has reopened a long-simmering debate for Chinese companies pursuing red-chip listings: should the holding company for the intellectual property (IP) be domiciled onshore in the PRC or offshore in a common law jurisdiction such as the Cayman Islands or BVI? The decision, which clarifies the HKEX’s stance on the “control” requirement under Chapter 8 of the Main Board Listing Rules, explicitly states that an offshore holding entity must demonstrate “substantive economic substance” beyond mere legal ownership of IP. This shift, combined with the PRC’s 2024 amendments to the Technology Contract Law and the State Administration of Taxation’s (SAT) increased scrutiny of cross-border IP royalty payments under Circular 16 (2024), has made the choice of IP holding location a critical determinant of both listing eligibility and ongoing tax efficiency. For CFOs and sponsors structuring a red-chip deal, the decision is no longer binary; it is a risk-weighted calculation involving regulatory compliance, tax leakage, and future M&A flexibility.

The Regulatory Landscape: Why 2025 Changed the Calculus

The HKEX’s 2025 clarification on Listing Rule 8.05(1)(c) — which requires a listing applicant to have “control” over its core assets — has introduced a material threshold for offshore IP holding companies. Prior to this, many red-chip structures placed IP in a BVI or Cayman subsidiary without rigorous scrutiny of the operational nexus between the IP owner and the PRC operating entity. The HKEX now requires that an offshore IP holder demonstrate that it exercises “active and substantive management” over the IP, not merely passive receipt of royalties. This is evidenced by the presence of a board of directors with decision-making authority in the offshore jurisdiction, physical or virtual operational meetings, and the ability to enforce IP rights independently of the PRC entity. Failure to meet this standard can result in a rejection of the listing application or, at minimum, a requirement to restructure post-listing.

Simultaneously, the SAT’s Circular 16 (2024) has tightened the definition of “beneficial ownership” for IP royalty payments made from a PRC subsidiary to an offshore parent. Under the circular, a Hong Kong or BVI IP holder must demonstrate that it has the “right to use, dispose of, and derive income from” the IP in its own name, not merely as a conduit for a PRC entity. The SAT has issued guidance indicating that it will apply a “substance-over-form” test, examining factors such as the number of employees in the offshore jurisdiction, the frequency of board meetings, and the existence of independent IP licensing agreements. This has direct implications for the withholding tax rate applicable to royalty payments: a Hong Kong IP holder that can demonstrate beneficial ownership can qualify for the 7% withholding tax rate under the PRC-Hong Kong Double Tax Arrangement (DTA), compared to the standard 10% rate for non-treaty jurisdictions. A BVI IP holder, which has no DTA with the PRC, is subject to the full 10% withholding tax on all royalty outflows.

Onshore IP Holding: The PRC-Domiciled Approach

Regulatory Simplicity and Listing Compliance

Holding IP directly in the PRC operating entity or a wholly-owned PRC subsidiary offers the most straightforward path to compliance with the HKEX’s “control” requirement under Listing Rule 8.05. The IP is legally owned by the entity that generates the revenue and employs the R&D staff, eliminating any ambiguity about “substantive economic substance.” For companies with IP that is central to their core business — such as a proprietary algorithm or a patented manufacturing process — this structure avoids the risk of the HKEX challenging the offshore entity’s ability to manage the IP independently. The 2025 HKEX decision explicitly notes that where IP is held onshore, the listing applicant is deemed to have “direct control” over the asset, provided the PRC entity is the registered owner under the PRC Patent Law or Copyright Law.

From a tax perspective, an onshore IP holder eliminates the need for cross-border royalty payments entirely. The PRC operating entity can deduct R&D expenses directly against its PRC corporate income tax (CIT) liability, which is currently at a standard rate of 25% but can be reduced to 15% for High and New Technology Enterprises (HNTE). The 2023 amendments to the PRC Enterprise Income Tax Law (EIT Law) further allow for a 100% super-deduction on qualifying R&D expenses, effectively reducing the effective tax cost of developing IP. For a company with annual R&D expenditure of RMB 100 million, this super-deduction can reduce its CIT liability by RMB 25 million per annum, a benefit that is lost if the IP is moved offshore.

Structural Limitations and Exit Constraints

The primary disadvantage of onshore IP holding is its impact on future exit strategies and cross-border M&A. If the PRC entity holds the IP, any sale of the IP to a third-party acquirer — whether foreign or domestic — is subject to the PRC’s strict technology transfer regulations under the 2020 Technology Import and Export Administration Regulations. For IP classified as “restricted” under these regulations, the transfer requires approval from the Ministry of Commerce (MOFCOM), a process that can take 6-12 months and is subject to discretionary denial. This creates a material liquidity risk for investors who may wish to monetize the IP through a sale or license post-IPO.

Furthermore, an onshore IP holder creates a structural tax inefficiency for any future cross-border licensing arrangements. If the PRC entity wishes to license the IP to a foreign subsidiary — for example, to support a regional expansion into Southeast Asia — the PRC entity must recognize the licensing income as PRC-sourced income and pay CIT at the standard 25% rate. The foreign subsidiary’s jurisdiction may also impose withholding tax on the royalty payment, leading to double taxation unless a DTA is in place. This is in contrast to an offshore IP holder, which can structure licensing income to be taxed in a low-tax jurisdiction such as Hong Kong (at a 16.5% profits tax rate) or the BVI (0%), and then repatriate the income to the PRC entity as a dividend, which may be tax-exempt under the DTA.

Offshore IP Holding: The Cayman Islands and BVI Approaches

The Cayman Islands Structure: Tax Neutrality and Listing Flexibility

The Cayman Islands remains the jurisdiction of choice for the ultimate holding company in a red-chip structure, but using a Cayman subsidiary to hold IP directly introduces a specific set of considerations. Under the Cayman Islands’ 2024 amendments to the Companies Act (as revised), a Cayman IP holding company must maintain a “registered office” and a “resident director” to qualify for the 0% corporate tax rate on foreign-sourced income. The Cayman Islands does not impose withholding tax on royalty payments made to or from the jurisdiction, making it a tax-neutral conduit for IP licensing. However, the PRC’s SAT has historically been skeptical of Cayman IP holders, given the jurisdiction’s lack of a DTA with the PRC. The 2024 SAT Circular 16 explicitly lists the Cayman Islands as a “high-risk jurisdiction” for treaty shopping, meaning that a Cayman IP holder will almost certainly be subject to the full 10% PRC withholding tax on any royalty payments from its PRC subsidiary.

The HKEX’s 2025 decision adds another layer of complexity for Cayman IP holders. The exchange now requires that a Cayman IP holder demonstrate “substantive economic substance” in the Cayman Islands, which is difficult to achieve without a physical office, employees, and a bank account in the jurisdiction. The 2024 Cayman Islands Economic Substance Law (ESL) already requires any entity engaged in “intellectual property business” to have adequate premises, staff, and expenditure in the Cayman Islands. Failure to comply with the ESL can result in a penalty of up to KYD 200,000 (approximately HKD 2.4 million) and potential strike-off from the register. For a typical red-chip issuer with a single IP asset, the cost of maintaining a Cayman IP subsidiary with substantive substance — including a local director, a serviced office, and an annual audit — is estimated at USD 50,000-80,000 per annum, a material overhead for a structure that may offer limited tax benefits.

The BVI Structure: Tax Efficiency and the Substance Challenge

The British Virgin Islands (BVI) has traditionally been the preferred jurisdiction for IP holding in red-chip structures, due to its 0% corporate tax rate on all income and its flexible legal framework under the BVI Business Companies Act (Cap. 216). A BVI IP holder can license IP to a PRC operating entity at a royalty rate of 5-10% of revenue, with the royalty income being tax-free in the BVI. The BVI also offers the ability to use a “hybrid” structure, where the IP is held by a BVI company that is tax-resident in Hong Kong, thereby qualifying for the 7% PRC withholding tax rate under the PRC-Hong Kong DTA. This structure requires the BVI company to have its “central management and control” in Hong Kong, evidenced by board meetings held in Hong Kong, a Hong Kong bank account, and a Hong Kong-resident director.

The 2025 HKEX decision, however, has cast doubt on the viability of the BVI IP holder in a red-chip listing. The exchange’s guidance states that an offshore IP holder must demonstrate “independent decision-making authority” over the IP, which is difficult to achieve when the BVI entity’s only function is to receive royalties and pay dividends to the Cayman parent. The HKEX has indicated that it will look at the “substance of the IP management function” — specifically, who makes decisions about licensing terms, enforcement actions, and R&D direction. If these decisions are made by the PRC operating entity’s management, the offshore IP holder is deemed to be a “passive conduit” and the listing applicant fails the control test. This has led to a number of pre-IPO restructurings in 2025, where companies have moved IP back onshore to satisfy the HKEX’s requirements.

The Hong Kong IP Holder: A Middle Ground?

The Hong Kong Advantage: Treaty Access and Regulatory Familiarity

Hong Kong has emerged as a pragmatic compromise for IP holding in red-chip structures, particularly for companies seeking a dual-primary listing on the HKEX. A Hong Kong-incorporated IP holder can benefit from the PRC-Hong Kong DTA, which reduces the withholding tax rate on royalty payments from the standard 10% to 7%, provided the Hong Kong entity is the “beneficial owner” of the IP. The Hong Kong Inland Revenue Department (IRD) has issued Departmental Interpretation and Practice Notes (DIPN) No. 46 (2023), which clarifies the beneficial ownership test: the Hong Kong IP holder must have the “right to use and exploit” the IP in its own name, must have “active business operations” in Hong Kong, and must not be a “conduit” for a third-party jurisdiction. This is a lower bar than the SAT’s “substance-over-form” test, but still requires the Hong Kong entity to have a physical office, at least one employee, and a Hong Kong bank account.

From a listing compliance perspective, a Hong Kong IP holder is treated more favorably by the HKEX than a BVI or Cayman holder. The exchange’s 2025 decision notes that a Hong Kong-incorporated entity is “presumed to have substantive economic substance” if it has a registered address in Hong Kong, a Hong Kong-resident director, and a Hong Kong auditor. This presumption can be rebutted if the HKEX finds that the IP management function is effectively outsourced to the PRC entity, but the burden of proof is on the exchange, not the applicant. For a company with annual IP-related revenue of HKD 500 million or more, the cost of maintaining a Hong Kong IP subsidiary — including office rent, director fees, and audit costs — is estimated at HKD 1.5-2.5 million per annum, which is offset by the 3% withholding tax savings compared to a BVI structure.

The Practical Limitations: Scale and Scope

The Hong Kong IP holder is not a panacea. The PRC’s SAT has become increasingly aggressive in challenging Hong Kong IP holders that lack “economic substance,” particularly in cases where the Hong Kong entity has no employees and no physical presence beyond a registered address. In a 2024 tax audit of a red-chip issuer in the biotech sector, the SAT re-characterized royalty payments from the PRC subsidiary to the Hong Kong IP holder as a “deemed dividend,” subjecting the payments to a 10% withholding tax (rather than the 7% DTA rate) and imposing a 20% penalty on the underpaid tax. The SAT’s rationale was that the Hong Kong entity had only one director (who was also a director of the PRC entity) and no independent decision-making authority over the IP. This case underscores the importance of ensuring that the Hong Kong IP holder has genuine operational substance, not merely legal form.

Furthermore, a Hong Kong IP holder introduces a layer of regulatory complexity that an onshore holder avoids. The Hong Kong entity must file annual tax returns with the IRD, even if it has no taxable profits (due to the 0% tax rate on foreign-sourced IP income under the Hong Kong territorial tax system). The IRD has the authority to audit the Hong Kong entity’s books and records, and can assess additional tax if it determines that the IP income is “Hong Kong-sourced” — for example, if the IP is licensed to a Hong Kong entity or if the licensing negotiations take place in Hong Kong. This risk can be mitigated by ensuring that the IP licensing agreement is executed in the PRC and that all negotiations occur between the PRC operating entity and the Hong Kong IP holder’s PRC-based representatives, but this adds to the administrative burden.

Actionable Takeaways for CFOs and Sponsors

1. For companies with IP that is central to their core business and no imminent cross-border M&A plan, hold the IP onshore in the PRC operating entity — this satisfies the HKEX’s 2025 “control” requirement without substance risk, and allows for the full benefit of PRC R&D super-deductions under the EIT Law.

2. For companies with a clear exit strategy involving a sale of the IP to a foreign acquirer, use a Hong Kong-incorporated IP holder with genuine operational substance — a physical office, at least one Hong Kong-resident employee, and independent board meetings — to qualify for the 7% DTA withholding tax rate and to meet the HKEX’s substantive economic substance test.

3. Avoid a BVI or Cayman IP holder in a red-chip listing unless the company has a pre-existing, audited track record of independent IP management in those jurisdictions — the SAT’s 2024 Circular 16 and the HKEX’s 2025 decision make it nearly impossible to satisfy both the tax and listing requirements without incurring disproportionate substance costs.

4. Conduct a pre-IPO substance audit of the IP holding entity at least 12 months before the intended listing date — engage a Big Four accounting firm to document the offshore entity’s decision-making processes, board minutes, and IP licensing agreements, and ensure that the entity can demonstrate independent control over the IP to the HKEX’s satisfaction.

5. Model the tax leakage of the IP holding structure under three scenarios — onshore, Hong Kong, and BVI/Cayman — using the SAT’s current beneficial ownership guidance and the PRC-Hong Kong DTA rates — the difference in effective tax rate between an onshore holder (15-25% CIT) and a Hong Kong holder (7% withholding tax) can be material, but must be weighed against the HKEX compliance risk and the cost of maintaining offshore substance.